ビジネス
通貨単位:EUR
2024/Q2
銘柄名売上高比率
Research and development of T cell redirecting immunotherapies for the treatment of cancer1,875.5万100.00%
地域
通貨単位:EUR
2023/通期
銘柄名売上高比率
BMS, United States5,069.5万93.88%
Moderna, United States536.9万9.94%
Genmab, Denmark-206.7万-3.83%